These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14600620)

  • 1. Bone cancer pain.
    Clohisy DR; Mantyh PW
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S279-88. PubMed ID: 14600620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone cancer pain.
    Clohisy DR; Mantyh PW
    Cancer; 2003 Feb; 97(3 Suppl):866-73. PubMed ID: 12548588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin diminishes advanced bone cancer pain.
    Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
    Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and the tumorigenic component of bone cancer pain.
    Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
    Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
    Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
    Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone cancer pain and the role of RANKL/OPG.
    Clohisy DR; Mantyh PW
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):293-300. PubMed ID: 15615497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.
    Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW
    Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in understanding bone cancer pain.
    Goblirsch MJ; Zwolak P; Clohisy DR
    J Cell Biochem; 2005 Nov; 96(4):682-8. PubMed ID: 16149079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms that generate and maintain bone cancer pain.
    Mantyh PW; Hunt SP
    Novartis Found Symp; 2004; 260():221-38; discussion 238-40, 277-9. PubMed ID: 15283453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism-based understanding of bone cancer pain.
    Mantyh PW
    Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
    Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain.
    El Mouedden M; Meert TF
    Pharmacol Biochem Behav; 2005 Sep; 82(1):109-19. PubMed ID: 16125759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
    Furuse S; Kawamata T; Yamamoto J; Niiyama Y; Omote K; Watanabe M; Namiki A
    Anesthesiology; 2009 Jul; 111(1):173-86. PubMed ID: 19512863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.
    Peters CM; Ghilardi JR; Keyser CP; Kubota K; Lindsay TH; Luger NM; Mach DB; Schwei MJ; Sevcik MA; Mantyh PW
    Exp Neurol; 2005 May; 193(1):85-100. PubMed ID: 15817267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.
    Yamamoto J; Kawamata T; Niiyama Y; Omote K; Namiki A
    Neuroscience; 2008 Feb; 151(3):843-53. PubMed ID: 18178319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the basic research on neurobiological mechanisms of cancer pain].
    Zhang Y; Han JS; Wang Y
    Sheng Li Ke Xue Jin Zhan; 2004 Jul; 35(3):224-8. PubMed ID: 15469092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion.
    Park HC; Seong J; An JH; Kim J; Kim UJ; Lee BW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1523-34. PubMed ID: 15817359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
    Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
    Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.
    Sevcik MA; Luger NM; Mach DB; Sabino MA; Peters CM; Ghilardi JR; Schwei MJ; Röhrich H; De Felipe C; Kuskowski MA; Mantyh PW
    Pain; 2004 Sep; 111(1-2):169-80. PubMed ID: 15327821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain.
    Mouedden ME; Meert TF
    Pharmacol Biochem Behav; 2007 Mar; 86(3):458-67. PubMed ID: 17306872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.